Collectively, these findings identify CXCL10 as a key chemokine upregulated upon PRMT5 deficiency, suggesting that PRMT5 may influence the recruitment of CD8+ T cells via the CXCL10 signaling pathway in cervical cancer. The gene discussed is CD8A; the disease is cervical carcinoma.